Renovaro BiosciencesRENB 
$0.53-2.96%24h
-2.96%24h
Global rank27151
Market cap$29.54M
Change 7d-9.48%
YTD Performance-83.33%
SP500 benchmarkUnderperform
P/E-0.74
P/S0
Revenue$0
Earnings-$39.68M
Dividend yield-
Main Sector
Healthcare
Renovaro Biosciences (RENB) Cash on Hand
RENB Cash on Hand in 2022: $1.87M
According to Renovaro Biosciences latest financial reports the cash on hand of RENB is $1.87M, an decrease of -79.56% to 2022. At the end of 2022 company had $9.17M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
RENB Cash on Hand History from 2019 to 2023
-
Value:-
RENB Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.87M | -79.56% |
| 2022 | $9.17M | -55.61% |
| 2021 | $20.66M | 137.62% |
| 2020 | $8.70M | -29.20% |
| 2019 | $12.28M | - |
View the Top Cash on Hand Companies 
